Home  |  Contact
Due to scheduled maintenance work, this service will not be available from Tuesday August 23rd 06:00 pm until Wednesday August 24th 08:00 am CEST. Apologies for the inconvenience.

Cellosaurus P3X63Ag8 (CVCL_3411)

[Text version]

Cell line name P3X63Ag8
Synonyms P3x63Ag8; P3-X63-Ag8; P3/X63-Ag8; P3/X63 Ag8; P3/X63/Ag8; P3-X63Ag8; P3X63 Ag8; P3x63 Ag8; P3 x 63Ag8; P3 X 63 Ag8; X63-Ag8; X63-AG8; x63-Ag8; P3X63; X63; GM03571
Accession CVCL_3411
Resource Identification Initiative To cite this cell line use: P3X63Ag8 (RRID:CVCL_3411)
Comments Group: Hybridoma fusion partner cell line.
Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
Doubling time: 16-26 hours (ECACC).
Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.
Misspelling: P3-X67Ag8; In PubMed=1172191 figures and table 1.
Disease Mouse plasma cell myeloma (NCIt: C125417)
Species of origin Mus musculus (Mouse) (NCBI Taxonomy: 10090)
Breed/subspecies: BALB/c.
Hierarchy Parent: CVCL_T278 (P3K)
Children:
CVCL_B0T4 (1083-17-1A )CVCL_A6LE (11/9 )CVCL_B0T5 (1116-56-2 )
CVCL_G218 (1116NS-19-9 )CVCL_7233 (1116NS-3d )CVCL_J039 (129A3/1 )
CVCL_J042 (130-3-F7-5 )CVCL_J040 (130C3/2B/8 )CVCL_J041 (132C4A/4 )
CVCL_J043 (143-2-A6-11 )CVCL_J081 (151-5-G2-12 )CVCL_J082 (151-5-G3-5 )
CVCL_J083 (151-6-A7-9 )CVCL_J084 (15F3-1 )CVCL_A0AE (168A51-2 )
CVCL_A0AF (168A51-42 )CVCL_A0AA (168B17-46-34 )CVCL_A0AB (168B17-46-50 )
CVCL_A0AC (168B17-46-70 )CVCL_A0AD (168B17-46-92 )CVCL_WS75 (18B8 )
CVCL_J099 (1A3 [Mouse hybridoma against HeLa] )CVCL_B0VL (1C1 [Mouse hybridoma against FeLV gp70] )CVCL_B0WJ (1C11 [Mouse hybridoma against FIV p24] )
CVCL_B0VM (1C12 [Mouse hybridoma against Feline leukemia virus p15E] )CVCL_J164 (1G12 )CVCL_B7G9 (1G7 [Mouse hybridoma against I.punctatis Ig light chain] )
CVCL_J165 (1H10-6 )CVCL_J511 (200-3-G6-4 )CVCL_CW45 (227-341-4 )
CVCL_J628 (2C5-6 )CVCL_J720 (3-83P )CVCL_B0WK (3B7 [Mouse hybridoma against FIV p24] )
CVCL_KB11 (3C5 [Mouse hybridoma against A.australis AaH2] )CVCL_B7GA (3F12 )CVCL_D292 (3H5-1 )
CVCL_B0VN (4B1 )CVCL_KB12 (4C1 [Mouse hybridoma against A.australis neurotoxin AaH2] )CVCL_J813 (4D12 [Mouse hybridoma against human B2M/HLA-B] )
CVCL_G092 (4F2C13 )CVCL_J887 (4SB3 )CVCL_J928 (5D4-11 )
CVCL_B6Q9 (691-13 )CVCL_B6QB (691-19 )CVCL_B6QD (691-2 )
CVCL_B6QF (691-4 )CVCL_B6QJ (691-6 )CVCL_B6Q7 (691-I-5Nu 4 )
CVCL_B0VP (6B2 [Mouse hybridoma against FeLV p15E] )CVCL_B0VQ (6D4 )CVCL_B0VR (6G3 )
CVCL_B0VS (7B3 )CVCL_J052 (7R2/A4 )CVCL_KS90 (8-18C5 )
CVCL_B0VT (8F3 )CVCL_KB13 (9C2 )CVCL_B0WP (A1.1 )
CVCL_XK76 (A17.2#1 )CVCL_J974 (A1G3 )CVCL_XK77 (A25.1#1B3 )
CVCL_7946 (A2B5 clone 105 )CVCL_A7QK (A3D8 )CVCL_L673 (Antibody 2.06 )
CVCL_XH98 (AS 2 )CVCL_XH99 (AS 3 )CVCL_J158 (Aw3.18.14 )
CVCL_J977 (B1 NIH )CVCL_B0WQ (B1.1 )CVCL_A2DD (B1.12 )
CVCL_XK78 (B16.1#1B2 )CVCL_XK79 (B16.1#1B6 )CVCL_XK80 (B16.1#1C1 )
CVCL_XK81 (B16.1#1C5 )CVCL_XK82 (B16.1#2A2 )CVCL_XK83 (B16.1#2A3 )
CVCL_XK84 (B16.1#2A5 )CVCL_XK85 (B16.1#2C4 )CVCL_XK86 (B16.1#2D2 )
CVCL_XK87 (B16.1#2D5 )CVCL_L832 (B1D6 )CVCL_B0WR (B2.1 )
CVCL_A2DE (B2.10 )CVCL_A2DF (B2.12 )CVCL_J978 (B3 NIH )
CVCL_B0WS (B3.1 )CVCL_J979 (B5 NIH )CVCL_4506 (BBM.1 )
CVCL_J449 (C11C1 )CVCL_KR90 (C17.9C6 )CVCL_B5N0 (CCM-52 )
CVCL_J890 (D1-4G2-4-15 )CVCL_J891 (D3-2H2-9-21 )CVCL_G367 (D8G )
CVCL_A1LH (DU-ALL-1 )CVCL_A6WW (ECCD-1 )CVCL_A6WX (ECCD-2 )
CVCL_J226 (F1-3G8-1 )CVCL_J237 (F11G )CVCL_H150 (GM03566 )
CVCL_H151 (GM03568 )CVCL_H149 (GM03705 )CVCL_JE56 (GM03713 )
CVCL_H152 (GM04279 )CVCL_H153 (GM04280 )CVCL_5J83 (H14-A11 )
CVCL_KR61 (H14-A2 )CVCL_5J84 (H14-A20 )CVCL_5J85 (H14-A21 )
CVCL_5J86 (H14-B18 )CVCL_5K02 (H18-S210 )CVCL_5K06 (H2-4B3 )
CVCL_5K07 (H2-4C2 )CVCL_5K08 (H2-6A1 )CVCL_B7B9 (H4A3 )
CVCL_B7BA (H4B4 )CVCL_B7BB (H4C4 )CVCL_B7BC (H4F8 )
CVCL_B7BD (H4H3 )CVCL_B7BE (H52 )CVCL_B7BF (H5A4 )
CVCL_B7BI (H5B9 )CVCL_B7BG (H5C6 )CVCL_B7BH (H5D2 )
CVCL_B7BJ (H5G11 )CVCL_L842 (H6/31HL )CVCL_5J96 (H9-A15 )
CVCL_5J97 (H9-D3 )CVCL_E979 (HFN 36.3 )CVCL_E980 (HFN 7.1 )
CVCL_3441 (HK-PEG-1 )CVCL_2502 (HO-13-4 )CVCL_2503 (HO-2.2 )
CVCL_2504 (HO-22-1 )CVCL_VU59 (Hybrid 15B )CVCL_VU60 (Hybrid 26A7 )
CVCL_VU61 (Hybrid 27-1 )CVCL_A2IG (I101C9-R1A5 )CVCL_A2IH (I101D4-R1D8 )
CVCL_A2IK (I101F5-R1G2 )CVCL_A2II (I101F8-R1G5 )CVCL_A2IJ (I101H12-R1GB )
CVCL_DC76 (IgE-14-205 )CVCL_G127 (IL-A11 )CVCL_L579 (IL-A12 )
CVCL_B6SG (IST-1 [Mouse hybridoma against human FN] )CVCL_B6SH (IST-2 )CVCL_B6SI (IST-3 )
CVCL_B6SJ (IST-4 )CVCL_B6SK (IST-9 )CVCL_G198 (J5 [Mouse hybridoma] )
CVCL_J814 (LS-136 )CVCL_L582 (Mab 126 )CVCL_L583 (mAb 13-1 )
CVCL_L584 (mAb 13-2 )CVCL_L588 (mAb 24-1 )CVCL_L589 (mAb 24-2 )
CVCL_A6QY (MAO A-3C9 )CVCL_A6QZ (MAO A-4F10 )CVCL_A6RA (MAO A-7B10 )
CVCL_A6RB (MAO A-7E10 )CVCL_A6QX (MAO B-1C2 )CVCL_A6GC (MAR 103.6 )
CVCL_D294 (MAR 18.5 )CVCL_A6FM (MAR 80.2 )CVCL_B6S1 (ME109 )
CVCL_B6S2 (ME121 )CVCL_B6S3 (ME165 )CVCL_B6S4 (ME325 )
CVCL_B6S5 (ME416 )CVCL_B6S6 (ME425 )CVCL_B6S7 (ME491 )
CVCL_B6S8 (ME492 )CVCL_B6S9 (ME493 )CVCL_B6SA (ME510 )
CVCL_B6SB (ME515 )CVCL_A8Q8 (MSN-1 )CVCL_L534 (MT3/B4 )
CVCL_L535 (MT4/E4 )CVCL_UZ12 (P3-Ag8-gamma1- )CVCL_2155 (P3/NS1/1-Ag4.1 )
CVCL_4032 (P3X63Ag8.653 )CVCL_3412 (P3X63Ag8U.1 )CVCL_LI05 (PI 125/10 )
CVCL_G250 (PI 153/3 )CVCL_B5N1 (RCM-25 )CVCL_B5N2 (RCM-37 )
CVCL_LG30 (Rx 54-3 )CVCL_B6QL (SK 37-7 )CVCL_A6PE (Sp1/7-2 )
CVCL_2199 (Sp2/0-Ag14 )CVCL_A6PD (Sp2/3-3 )CVCL_D677 (SXC1 )
CVCL_J096 (SXC2 )CVCL_F770 (T3-3A1 )CVCL_G093 (T3-5E9 )
CVCL_F784 (TE4 [Mouse hybridoma] )CVCL_A2IA (V81C6-R1B6 )CVCL_A2IB (V82A6-R1C4 )
CVCL_A2IF (V82B1-R2D4 )CVCL_A2IC (V82B2-R1F6 )CVCL_A2IE (V82G12-R1G1 )
CVCL_A2ID (V82G3-R1D6 )CVCL_B0D1 (VIIIC3.78 )CVCL_7872 (W6/32 )
CVCL_F817 (XMMME-001 )CVCL_F818 (XMMME-002 )CVCL_2Z37 (Y8-10C2 )
Sex of cell Female
Category Cancer cell line
Publications

PubMed=1172191; DOI=10.1038/256495a0
Kohler G.J.F., Milstein C.
Continuous cultures of fused cells secreting antibody of predefined specificity.
Nature 256:495-497(1975)

PubMed=825377; DOI=10.1002/eji.1830060713
Kohler G.J.F., Milstein C.
Derivation of specific antibody-producing tissue culture and tumor lines by cell fusion.
Eur. J. Immunol. 6:511-519(1976)

PubMed=6769123; DOI=10.1073/pnas.77.4.2197
Kohler G.J.F.
Immunoglobulin chain loss in hybridoma lines.
Proc. Natl. Acad. Sci. U.S.A. 77:2197-2199(1980)

PubMed=2108149; DOI=10.1016/S0021-9258(19)39438-4
Lee S.-O., Connolly J.M., Ramirez-Soto D., Poretz R.D.
The polypeptide of immunoglobulin G influences its galactosylation in vivo.
J. Biol. Chem. 265:5833-5839(1990)

CLPUB00447
Mulivor R.A., Suchy S.F.
1992/1993 catalog of cell lines. NIGMS human genetic mutant cell repository. 16th edition. October 1992.
(In) Institute for Medical Research (Camden, N.J.) NIH 92-2011; pp.1-918; National Institutes of Health; Bethesda (1992)

Cross-references
Cell line collections ATCC; TIB-9
BCRC; 60340
Coriell; GM03571
ECACC; 85011401
ICLC; ATL05001
JCRB; JCRB9105
NCI-DTP; P3X63
Cell line databases/resources CLO; CLO_0008334
CLO; CLO_0017237
CLDB; cl3840
CLDB; cl3841
CLDB; cl7165
CCRID; 3101MOUTCM9
Lonza; 186
Anatomy/cell type resources BTO; BTO:0001118
Encyclopedic resources Wikidata; Q54937286
Entry history
Entry creation04-Apr-2012
Last entry update23-Sep-2021
Version number27